141 related articles for article (PubMed ID: 15501357)
1. [Hypertrophic myopathy due to muscular metastasis of a signet cell adenocarcinoma of the bladder].
Brénuchon C; Launay D; Maurage CA; Queyrel V; Lambert M; N'Guyen HD; Boutry N; Hachulla E; Hatron PY; Devulder B
Rev Med Interne; 2004 Nov; 25(11):839-41. PubMed ID: 15501357
[No Abstract] [Full Text] [Related]
2. Retrospective analysis of the efficacy and safety of neoadjuvant gemcitabine and cisplatin in muscle-invasive bladder cancer.
Meleis L; Moore R; Inman BA; Harrison MR
J Oncol Pharm Pract; 2020 Mar; 26(2):330-337. PubMed ID: 31081469
[TBL] [Abstract][Full Text] [Related]
3. Treatment of metastatic urothelial cancer in the post-MVAC era.
Cohen EE; Stadler WM
World J Urol; 2001 Apr; 19(2):126-32. PubMed ID: 11374315
[TBL] [Abstract][Full Text] [Related]
4. Meningeal carcinomatosis as the presenting manifestation of gastric adenocarcinoma.
Deeb LS; Yamout BI; Shamseddine AI; Shabb NS; Uthman SM
Am J Gastroenterol; 1997 Feb; 92(2):329-31. PubMed ID: 9040217
[TBL] [Abstract][Full Text] [Related]
5. Best cases from the AFIP: urachal carcinoma.
Koster IM; Cleyndert P; Giard RW
Radiographics; 2009; 29(3):939-42. PubMed ID: 19448126
[No Abstract] [Full Text] [Related]
6. Good response chemotherapy for late-recurring gastric cancer in the gluteals, with peritoneal and retroperitoneal dissemination.
Sakuma T; Deguchi R; Takashimizu S; Ogasawara F; Numata M; Ohtani Y; Sato S; Mine T; Iwata Y
Tokai J Exp Clin Med; 2011 Apr; 36(1):8-12. PubMed ID: 21547886
[TBL] [Abstract][Full Text] [Related]
7. Lack of pathologic down-staging with neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma of the bladder: a contemporary series.
Weight CJ; Garcia JA; Hansel DE; Fergany AF; Campbell SC; Gong MC; Jones JS; Klein EA; Dreicer R; Stephenson AJ
Cancer; 2009 Feb; 115(4):792-9. PubMed ID: 19127557
[TBL] [Abstract][Full Text] [Related]
8. Skeletal muscle metastases as initial presentation of gastric carcinoma.
Pergolini I; Crippa S; Santinelli A; Marmorale C
Am J Case Rep; 2014 Dec; 15():580-3. PubMed ID: 25544018
[TBL] [Abstract][Full Text] [Related]
9. Comparative effectiveness of gemcitabine plus cisplatin versus methotrexate, vinblastine, doxorubicin, plus cisplatin as neoadjuvant therapy for muscle-invasive bladder cancer.
Galsky MD; Pal SK; Chowdhury S; Harshman LC; Crabb SJ; Wong YN; Yu EY; Powles T; Moshier EL; Ladoire S; Hussain SA; Agarwal N; Vaishampayan UN; Recine F; Berthold D; Necchi A; Theodore C; Milowsky MI; Bellmunt J; Rosenberg JE;
Cancer; 2015 Aug; 121(15):2586-93. PubMed ID: 25872978
[TBL] [Abstract][Full Text] [Related]
10. Gluteal muscular and sciatic nerve metastases in advanced urinary bladder carcinoma: case report.
Nagao E; Nishie A; Yoshimitsu K; Irie H; Shioyama Y; Naito S; Matsuura S; Honda H
Abdom Imaging; 2004; 29(5):619-22. PubMed ID: 15162230
[TBL] [Abstract][Full Text] [Related]
11. Signet-ring cell carcinoma of unknown primary location. Metastatic to lower back musculature - remission following FU/FA chemotherapy.
Heidemann J; Gockel HR; Winde G; Herbst H; Domschke W; Lügering N
Z Gastroenterol; 2002 Jan; 40(1):33-6. PubMed ID: 11803498
[TBL] [Abstract][Full Text] [Related]
12. Enlarged extraocular muscles from metastatic signet ring carcinoma.
Loes L; Wesley RE; Lavin P
Ophthalmic Surg Lasers; 1996 Jul; 27(7):632-5. PubMed ID: 9240782
[TBL] [Abstract][Full Text] [Related]
13. Signet ring cell adenocarcinoma of the ampulla of Vater: a rare pathology.
Lesquereux-Martínez L; Fernández-Pérez A; Bustamante-Montalvo M
Rev Esp Enferm Dig; 2012 Sep; 104(9):501-2. PubMed ID: 23130863
[No Abstract] [Full Text] [Related]
14. Durable control of small cell carcinoma of the urinary bladder by gemcitabine and paclitaxel.
Matsui Y; Fujikawa K; Iwamura H; Oka H; Fukuzawa S; Takeuchi H
Int J Urol; 2002 Feb; 9(2):122-4. PubMed ID: 12033198
[No Abstract] [Full Text] [Related]
15. [Elevation of CA 19.9 in urothelial bladder cancer].
Bastos Oreiro M; López Rodríguez M; Monedero Martín MC; Plasencia Rodríguez C
Med Clin (Barc); 2008 Mar; 130(8):319. PubMed ID: 18358126
[No Abstract] [Full Text] [Related]
16. [Short-term outcome of neoadjuvant gemcitabine-carboplatin therapy for muscle-invasive bladder cancer].
Yamato T; Okamoto A; Imai A; Ishimura D; Hatakeyama S; Hagisawa S; Iwabuchi I; Yoneyama T; Mori K; Koie T; Ohyama C
Gan To Kagaku Ryoho; 2008 Jan; 35(1):83-6. PubMed ID: 18195533
[TBL] [Abstract][Full Text] [Related]
17. Intravesical therapy for superficial cancer: need for more options.
Crawford ED
J Clin Oncol; 2002 Aug; 20(15):3185-6. PubMed ID: 12149286
[No Abstract] [Full Text] [Related]
18. Colon and gastric metastases from a primary signet-ring cell carcinoma of the urinary bladder.
Morelli O; Castellani D; Asciutti S; Baldoni M; Familiari L; Nardi E; Morelli A; Clerici C
Dig Liver Dis; 2006 Aug; 38(8):609-11. PubMed ID: 16551516
[TBL] [Abstract][Full Text] [Related]
19. Gemcitabine-induced vasculitis in advanced transitional cell carcinoma of the bladder.
Birlik M; Akar S; Tuzel E; Onen F; Ozer E; Manisali M; Kirkali Z; Akkoc N
J Cancer Res Clin Oncol; 2004 Feb; 130(2):122-5. PubMed ID: 14745551
[TBL] [Abstract][Full Text] [Related]
20. Gemcitabine in intravesical treatment of Ta-T1 transitional cell carcinoma of the bladder.
Campodonico F; Maffezzini M
Urology; 2005 Nov; 66(5):1141-2; author reply 1142. PubMed ID: 16286156
[No Abstract] [Full Text] [Related]
[Next] [New Search]
